| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 458.50B | 409.08B | 373.71B | 345.71B | 343.36B |
| Gross Profit | 122.51B | 109.50B | 97.30B | 85.17B | 78.83B |
| EBITDA | 64.64B | 56.97B | 50.43B | 43.29B | 41.26B |
| Net Income | 43.95B | 38.54B | 33.72B | 29.55B | 28.57B |
Balance Sheet | |||||
| Total Assets | 608.79B | 604.35B | 486.04B | 422.56B | 387.95B |
| Cash, Cash Equivalents and Short-Term Investments | 85.96B | 147.35B | 83.46B | 58.55B | 77.75B |
| Total Debt | 61.66B | 46.59B | 60.22B | 60.53B | 26.83B |
| Total Liabilities | 372.37B | 376.68B | 311.74B | 270.63B | 253.12B |
| Stockholders Equity | 223.22B | 216.75B | 162.88B | 142.94B | 124.87B |
Cash Flow | |||||
| Free Cash Flow | 42.20B | 52.67B | 51.59B | 27.31B | 28.27B |
| Operating Cash Flow | 53.35B | 60.51B | 57.90B | 34.66B | 35.09B |
| Investing Cash Flow | 25.34B | -87.90B | -31.22B | -13.51B | 13.60B |
| Financing Cash Flow | -64.96B | 22.70B | -17.91B | -10.85B | -31.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$649.86B | 13.16 | 19.76% | 5.00% | 12.46% | 9.95% | |
69 Neutral | HK$32.00B | 8.94 | 19.03% | 5.70% | 2.29% | 3.18% | |
68 Neutral | HK$210.36B | 23.80 | 16.61% | 5.20% | 19.14% | 14.07% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
46 Neutral | HK$6.06B | -35.44 | -4.81% | ― | 1.29% | -386.78% |